Retail Radar: Instacart's Public Plans; Walmart Ups Healthcare Options

Path to Purchase Institute members have access to regularly updated profiles, which can be accessed here. Recent news includes Instacart's IPO filing and PetSmart's "Nightmare" exclusive.

Instacart Files IPO

The retail platform has unpaused its plans to go public, filing an IPO with the SEC, with PepsiCo as a backer.

Walmart's Testing & Treatment Program

The mega retailer continues to grow its healthcare options, with a Testing & Treatment service that's launching in 12 states. Customers can get same-day diagnostics and prescription treatments or recommendations for products to soothe sore throats and more. Walmart also continues expanding its e-commerce options, with a new drone partner and rotisserie chicken deliveries a click away.

CVS Launches into Pharmaceuticals

The drugstore chain has formed Cordavis, which will work with manufacturers to produce biosimilar medications to fill at a lower price point. CVS and Sandoz first plan to bring Hyrimoz, a biosimilar for arthritis medicine Humira, to market sometime in 2024. 

PetSmart 'Nightmare' Exclusive

The pet retailer is helping celebrate the 30th anniversary of Tim Burton's "The Nightmare Before Christmas" with new pet costumes, toys, accessories and aquarium decor.

Circle K Day

The convenience store chain is holding its first Circle K Day today, with participating locations offering discounts on food, beverage, car washes, fuel and EV charges. (Due to Hurricane Idalia, the promotion is being postponed in Florida, Georgia, North Carolina and South Carolina.)